GSE173319
BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia  [single-cell multiomics]
Hijacking of primitive hematopoietic enhancers, or generation of a neo-enhancer by genomic amplification, results in deregulation of BCL11B as the defining feature of a subset of T/myeloid leukemia.  We report H3K27ac and BCL11B binding in these Leukemias. Overall design: Single cell multiomics using 10X Single Cell ATAC + Gene Expression